Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson’s disease models

Huntingtin interaction protein 2 (HIP2) is an E2 ubiquitin-conjugating enzyme associated with neurodegenerative diseases, and HIP2 mRNA has been implicated as a potential blood biomarker for Parkinson’s disease (PD). However, it is unclear whether the alteration of HIP2 expression may contribute to...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Jinlin, Huang, Pei, Qin, Meiling, Lu, Qingqing, Sang, Xiao, Cai, Yijun, Wang, Ying, Liu, Fubing, Wu, Rong, Wang, Xiaoping, Jiang, Xiaoxing, Wang, Jian, Sun, Qiang, Chen, Shengdi, Xu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170399/
https://www.ncbi.nlm.nih.gov/pubmed/30282965
http://dx.doi.org/10.1038/s41419-018-1066-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170399/
https://www.ncbi.nlm.nih.gov/pubmed/30282965
http://dx.doi.org/10.1038/s41419-018-1066-z

Ejemplares similares